This US single family office invests in life sciences [2022]

Rated 5.00 out of 5 €2.499,99 including VAT Rated 5.00 out of 5 €399,99 including VAT This article directly stems from the research process for our single family office database. Our list of life science focused single family offices includes the most important family investment vehicles that invest in life sciences and biotech. The list is based on a keyword crawler that analyzes our global list.You might also like the , created by our partner portal ThousandInvestors. Arie Belldegrun is an Israeli-American billionaire that has launched and invested in various pharma companies. The Tel-Aviv born entrepreneur is, for instance, founder of Agensys, which was sold to Astellas Pharma in 2007. Since 2003, Belldegrun is investing – together with his wife Rebecka Belldegrun – in various sectors through their family office Bellco Capital. Amongst the target sectors is the life science industry. In January 2021, the Bellco Capital invested in IconOVir. The firm develops a platform for oncolytic viruses that lead to anti-cancer responses and rapid tumor killing. Another investment of the pharma investor family office is UroGen Pharma, that works on non-surgical treatments for uro-oncology. Picture source:

User Comments1. Campbell, Daniel: Comment sample 1...2. Charlotte Nelson: Comment sample 2...3. Owen C.: Comment sample 3...4. Emma C.: Comment sample 4...5. Carter, Daniel: Comment sample 5...Editor's NoteThis article was refined for clarity, structure, and user experience.